The rapid advancement of precision medicine and next-generation therapeutics has significantly increased demand for specialized manufacturing capabilities across the biopharmaceutical industry. As the peptide contract manufacturing market expands and oligonucleotide manufacturing services become increasingly essential for RNA- and DNA-based therapies, pharmaceutical companies are relying more...